Cáncer de colon

Sobin, 2009 Popat, 2005, Systematic review of microsatellite instability and colorectal cancer prognosis, J Clin Oncol, 23, 609, 10.1200/JCO.2005.01.086 Lee, 2014, Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis, Ann Intern Med, 160, 171, 10.7326/M13-1484 TNCD: www.tncd.org. Recommandations SFED, 2007. Moertel, 1990, Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma, N Engl J Med, 322, 352, 10.1056/NEJM199002083220602 André, 2009, Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial, J Clin Oncol, 27, 3109, 10.1200/JCO.2008.20.6771 Quasar Collaborative Group, 2007, Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study, Lancet, 370, 2020, 10.1016/S0140-6736(07)61866-2 Tournigand, 2012, J Clin Oncol, 30, 3353, 10.1200/JCO.2012.42.5645 Taieb, 2014, Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial, Lancet Oncol, 15, 862, 10.1016/S1470-2045(14)70227-X Falcone, 2007, J Clin Oncol, 25, 1670, 10.1200/JCO.2006.09.0928 Ducreux, 2005, Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Fédération Nationale des Centres de Lutte Contre le Cancer, J Clin Oncol, 23, 4881, 10.1200/JCO.2005.05.120